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Background: Deﬁcits in motivational salience processing have been related to psychotic symptoms and distur-
bances in dopaminergic neurotransmission. We aimed at exploring changes in salience processing and brain
activity during different stages of psychosis and antipsychotic medication effect.
Methods:We used fMRI during the Salience Attribution Task to investigate hemodynamic differences between
19 healthy controls (HCs), 34 at-risk mental state (ARMS) individuals and 29 individuals with ﬁrst-episode
psychosis (FEP), including a subgroup of 17 FEPwithout antipsychoticmedication (FEP-UM) and 12 FEPwith an-
tipsychotic medication (FEP-M). Motivational salience processing was operationalized by brain activity in re-
sponse to high-probability rewarding cues (adaptive salience) and in response to low-probability rewarding
cues (aberrant salience).
Results: Behaviorally, adaptive salience responsewasnot accelerated in FEP, although they correctly distinguished
between trialswith low and high reward probability. In comparison to HC, ARMS exhibited a lower hemodynam-
ic response during adaptive salience in the right inferior parietal lobule and FEP-UM in the left dorsal cingulate
gyrus. The FEP-M group exhibited a lower adaptive salience response than HC in the right insula and than
ARMS in the anterior cingulate gyrus. In unmedicated individuals, the severity of hallucinations and delusions
correlated negatively with the insular- and anterior cingulate hemodynamic response during adaptive salience.
We found no differences in aberrant salience processing associated with behavior or medication.
Conclusion: The changes in adaptive motivational salience processing during psychosis development reveal
neurofunctional abnormalities in the somatosensory and premotor cortex. Antipsychotic medication seems to
modify hemodynamic responses in the anterior cingulate and insula.© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Aberrant salience processing has been proposed as a pathophysiolog-
ical hallmark of psychosis (Kapur, 2003). Positive psychotic symptoms
(hallucinations and delusions) result from inappropriate attribution of
motivational properties to stimuli, thoughts and percepts (Kapur, 2003).
Motivational salience transforms the brain's neutral representations of
conditioned stimuli into attractive representations and ‘grabs attention’
(Berridge and Robinson, 1998). Adaptive motivational salience refers to
stimuli with a reliable association with reinforcement and which can
therefore inﬂuence behavior and attract attention (Roiser et al., 2009). Inics (UPK) Basel, Wilhelm Klein
9.
. This is an open access article undercontrast, aberrant salience refers to stimuli that have no reliable associa-
tionwith reinforcement but come to be attention-grabbing andwhich in-
appropriately capture thought- and goal-directed behavior (Jensen and
Kapur, 2009). Adaptive and aberrantmotivational saliences have been op-
erationalized using aprobabilistic reward-learning task, the SalienceAttri-
bution Task (SAT) (Roiser et al., 2009). This task can distinguish between
the use of relevant cues (adaptive salience) and irrelevant cues (aberrant
salience). In the SAT, adaptivemotivational salience is deﬁned as the in-
crease in probability ratings (the explicit measure) or acceleration of re-
sponses (the implicit measure) to stimuli strongly associated with
reward, relative to those weakly associated with reward (Roiser et al.,
2009). Aberrantmotivational salience is deﬁned as the absolute difference
in acceleration or probability ratings between the two levels of the task-
irrelevant stimulus dimension (Roiser et al., 2009).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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lience processing and aberrant salience processing occur in partially
overlapping (Roiser et al., 2010) or even in identical neurocircuits
(Roiser et al., 2013). In healthy controls (HCs), cues associated with
adaptive salience elicited greater activation in the midbrain, thalamus,
superior temporal gyrus, insula, ventral striatum and cerebellum
(Roiser et al., 2010), with similar effects in individuals with an at-risk
mental state (ARMS) (Roiser et al., 2013). Chronic schizophrenia pa-
tients exhibited (a) increased aberrant salience responses in the stria-
tum, hippocampus and prefrontal regions than with HC (Diaconescu
et al., 2011) and (b) lower adaptive salience responses in the striatum
(Gradin et al., 2013; Grimm et al., 2012), amygdala, hippocampus, and
midbrain (Gradin et al., 2013). The only fMRI study on salience process-
ing with ARMS demonstrated elicited adaptive salience brain responses
in the ventral striatumbut did notﬁnddifferences fromHC(Roiser et al.,
2013).
Psychotic patients treated with antipsychotics showed behavioral
impairments in adaptive salience (Roiser et al., 2009), consistent with
reinforcement-associated abnormal brain responses in medicated
schizophrenia patients (Murray et al., 2008; Waltz et al., 2009).
Dopaminergic agonists facilitate (Nagy et al., 2012; Pessiglione et al.,
2006), while antipsychotics attenuate motivational salience (Kapur,
2003), leading to undesired effects, e.g. loss of motivation, apathy and
anhedonia (Roiser et al., 2009).
In the present study, we focused on hemodynamic responses during
motivational salienceprocessing and their relationship to hallucinations
and delusions in emerging psychosis.We ﬁrstly hypothesized that there
were differences in whole-brain activity in ARMS and unmedicated FEP
patients (FEP-UM) relative to HCs. Secondly, we expected that
antipsychotic-medicated FEP patients (FEP-M) would exhibit lower re-
sponses in salience-related brain regions than did patients without cur-
rent antipsychotic medication (FEP-UM). Thirdly, given the relation
between salience processing and positive symptoms (Roiser et al.,
2013), we further testedwhether salience-related brain activity was re-
lated to positive symptoms (hallucinations and delusions) in ARMS and
FEP patients.2. Materials and methods
2.1. Study population
The Early Detection of Psychosis (FePsy), Psychiatric University
Clinics in Basel, Switzerland, recruited and followed up ARMS and FEP
individuals (Riecher-Rossler et al., 2009). This is an ongoing prospective
naturalistic study and all individuals includedwere assessed for current
symptoms at the time of the MRI scan (for details see supplement).
The ARMS (N = 34) individuals were characterized using the Basel
Screening Instrument for Psychosis (Riecher-Rössler et al., 2007), iden-
tical with the Comprehensive Assessment of ARMS (CAARMS) criteria
(Yung et al., 2005): a) “attenuated” psychotic symptoms; b) brief limit-
ed intermittent psychotic symptoms; or c) a ﬁrst-degree relative with a
psychotic disorder plus a marked decline in social or occupational
functioning. After 33.3 months of clinical follow-up, 6 ARMS individuals
transited to psychosis. All but one ARMS individual were antipsychotic-
naïve. Eleven of the ARMS individuals were receiving antidepressants.
The FEP patients (N= 29) fulﬁlled the criteria for acute psychotic
disorder according to the ICD-10 or DSM-IV, but not yet for schizo-
phrenia (Yung et al., 1998). The transition to psychosis in ARMS indi-
viduals was deﬁned by the CAARMS criteria (Yung et al., 1998). The
mean duration of psychosis was 7.76 months (SD = 15.77 months),
with an upper limit of 5 years. We divided FEP according to their cur-
rent status of antipsychotic medication: 17 FEP-UM were without
current antipsychotic medication and 12 FEP-M were receiving
atypical antipsychotics. Ten of the FEP group (N = 5 in FEP-M)
were taking antidepressants.The 19 HCs, from the same geographical area, had no history of
psychiatric or neurological disorder, head trauma, serious illness, or
substance abuse, assessed by an experienced psychiatrist.
General exclusion criteria were: history of previous psychotic disor-
der, psychotic symptomatology secondary to an ‘organic’ disorder, re-
cent substance abuse according to ICD-10 research criteria, psychotic
symptomatology associated with an affective psychosis or a borderline
personality disorder, age under 18 years, inadequate German knowl-
edge, and IQ b 70 (measured using the multiple choice vocabulary-
intelligence test (MWT-B)). All participants provided written informed
consent and received compensation for participating. The local ethics
committee approved the study.
2.2. Salience Attribution Task (SAT)
Neural and behavioral responses during motivational salience pro-
cessing were assessed with the SAT (Roiser et al., 2009, 2010). Partici-
pants had to respond quickly to the presentation of a square. Money
was available in 50% of trials, with the likelihood of reward in a given
trial signaled by one of four categories of cues. The cues varied in two
different visual dimensions, with one of these cue dimensions being
task-relevant. Participants estimated reward probabilities for each
cue-category using visual analogue scales in %.
2.3. Statistical analysis of demographic and behavioral data
Data were analyzed using the Statistical Package for the Social
Sciences version 20.0 (SPSS Inc., Chicago, IL, USA). We used one-way
analysis of variance (ANOVA) and χ2 tests for demographic, clinical
and behavioral analyses. The Bonferroni correction (at P b 0.05)was ap-
plied for all post-hoc tests.
2.4. Magnetic resonance imaging acquisition
Participants were scanned using a whole-body 3 T MRI system
(Magnetom Verio, Siemens Healthcare, Erlangen, Germany). During
the SAT, we acquired T2*-weighted echo-planar images (EPIs) with
the following parameters: 38 axial slices of 3 mm thickness, 0.5 mm
interslice gap, ﬁeld of view 228 × 228 cm2 and an in-plane resolution
of 3 × 3 mm2. The repetition time was 2.5 s and the echo time 28 ms.
2.5. fMRI analysis
EPIs were analyzed using Statistical Parametric Mapping (SPM8,
www.ﬁl.ion.ucl.ac.uk/spm). Maximum likelihood parameter estimates
were calculated at the ﬁrst level at each voxel using the general linear
model. Our design matrix included an autoregressive AR(1) model of
serial correlations and a high-passﬁlterwith a cutoff of 128 s. The onsets
of each eventwere convolvedwith the SPM synthetic hemodynamic re-
sponse function and its temporal and dispersion derivatives. The ﬁrst
level design matrix included four cue regressors, an outcome regressor
and its parametric modulation by magnitude of reward (in Swiss
Francs); for more details see Roiser et al. (2010). Only adaptive and ab-
errant reward prediction contrasts entered the second-level analyses to
identify themain effect ofmotivational salience and between-groupdif-
ferences, using the summary statistics approach to random-effects
analysis.
We used a full factorial ANOVA to compare FEP-M and FEP-UM,
ARMS, andHCon the adaptive and aberrant reward prediction contrasts.
For between-group differences, signiﬁcance was assessed at a cluster-
level threshold of P b 0.05 FWE corrected across the whole brain,
using a cluster-forming threshold of P b 0.005 (uncorrected)
(Petersson et al., 1999). Effects were visualized in the FMRIB Software
Library Viewer and labeled using the incorporated atlas tools. Based
on the previously described essential roles of the insula and the anterior
cingulate cortex (ACC) in salience processing, along with their
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Liddle, 2012), we tested the correlation of the BPRS hallucination and
delusion score with activation in the right ACG and the right insula
during adaptive salience, using Spearman's ρ.
3. Results
3.1. Demographic and clinical characteristics
The groups were well matched for gender, age, handedness, and
verbal IQ. There was a signiﬁcant main effect of group on positive
and negative symptoms and global functioning (P b 0.0001). FEP-UM,
FEP-M and ARMS had more positive, negative psychotic symptoms
and worse global functioning than HC (P b 0.005). FEP-UM had
signiﬁcantly more positive symptoms (P b 0.0001) and worse global
functioning (P = 0.027) than ARMS (Table 1).
3.2. Behavioral characteristics
There was nomain effect of group in the overall ANOVA for adaptive
(explicit F(3,78) = 1.478, P = 0.227; implicit F(3,78) = 1.104, P =
0.353) or aberrant (explicit F(3,78) = 2.186, P = 0.096; implicit
F(3,78) = 1.115, P = 0.348) salience. Each group exhibited signiﬁcant
explicit adaptive, and explicit and implicit aberrant salience (one sample
t tests, P b 0.0001). The ARMS (t(33) = 4.63, P b 0.001) and HC groups
(t(18) = 4.63, P b 0.001) responded signiﬁcantly more quickly to
adaptive salience. However, neither the FEP-M group (t(11) = 0.67,
P = 0.52) nor FEP-UM (t(16)= 1.31, P = 0.21) showed any signiﬁcant
implicit adaptive salience (Supplementary Table 6).
3.3. fMRI data
3.3.1. Within-group analyses
Hemodynamic responses of adaptive, reverse adaptive, aberrant, and
reverse aberrant reward prediction in separate groups are presented in
Supplementary Tables 2, 3, 4, and 5.Table 1
Demographic and clinical data.
FEP-M (n = 12) FEP-UM (n = 17) ARMS (n = 34)
Gender M/F 6/6 13/4 26/8
Mean age in year (SD) 27.42 (7.9) 24.82 (5.7) 24.35 (5.5)
Handedness non-left/non-left 11/3 16/1 32/2
MWT-B IQ (SD) 105 (20) 103 (12) 113 (15)
BPRS total (SD) 42.75 (14.8) 51.71 (15.5) 39.67 (9.5)
BPRS 9 3.00 (1.7) 3.47 (1.4) 2.27 (1.2)
BPRS 10 2.50 (2.1) 3.53 (2.0) 1.55 (1.0)
BPRS 11 3.25 (1.9) 3.71 (1.9) 1.97 (1.3)
SusHalDel 8.75 (4.7) 10.71 (4.4) 5.79 (2.4)
SANS total (SD) 17.08 (16.2) 21.82 (14.9) 23.03 (15.2)
GAF total (SD) 63.50 (10.0) 53.06 (17.94) 64.13 (13.3)
Antipsychotic n AN/AF/Med 0/0/12 11/6/0 34/0/0
Antidepressants n (%) 5 (29%) 5 (24%) 11 (31%)
Alcohol n No/Mod/Uncon 2/6/4 7/9/1 8/17/9
Cannabis currently (%) 1 (8%) 7 (41%) 11 (32%)
Smoking (cig/day) 9.42 (18.42) 10.88 (11.5) 7.19 (9.8)
Bonferroni correction (at P = 0.05) was calculated for post-hoc analysis in SPSS 20.0. Abbrevi
intake of alcohol;Uncon, uncontrolleddrinking; Antipsychotic, antipsychoticmedication on the
ARMS, at-risk mental state individuals = A in the Post hoc column; BPRS, brief psychiatric rati
individuals who were medicated with antipsychotics at the time of testing = M in the Pos
testing = U in the Post hoc column; GAF, Global Assessment of Functioning; HC, healthy control
intelligence test); SANS; SusHalDel, BPRS 9 + BPRS 10 + BPRS 11, sum of suspiciousness, halluc3.3.2. Between-group analyses
Compared to HC, ARMS had signiﬁcantly lower hemodynamic re-
sponses during adaptive salience in the right inferior parietal lobule.
FEP-UM exhibited lower responses in the left dorsal cingulate gyrus
than HC (Fig. 1, Table 2). Compared to HC, there was less activation in
the whole FEP group in the right precentral gyrus and insula.
FEP-M exhibited lower hemodynamic responses than ARMS in the
bilateral cingulate gyri and than HC in the right insula (Fig. 2, Table 2).
We found hemodynamic responses in the ventral striatum and prefron-
tal cortex in all included groups. Nevertheless, there was no between-
group difference in these motivationally relevant regions.
The FEP-UM group exhibited higher aberrant salience responses
than HC in the right cuneus. HC exhibited a higher aberrant salience
response than ARMS and FEP in the left inferior parietal lobule
(Supplementary Table 1).
3.3.3. Correlation analyses of positive psychotic symptoms and insular and
anterior cingulate activation
The FEP-UM group showed negative correlation between insular ac-
tivation and hallucinations (r=−0.643, P=0.005; survived correction
for multiple comparison). If ARMS and FEP-UMwere pooled, there was
a negative correlation between ACG activation and delusions
(r=−0.245, P=0.013), but this did not survive the correction formul-
tiple comparison; Fig. 3.
4. Discussion
We explored the neural correlates of motivational salience process-
ing in subjects with an ARMS for psychosis and in FEP patients. Attenu-
ated adaptive salience-related responses in the dorsal cingulate cortex
were found in unmedicated FEP patients, reﬂecting psychosis-
associated deﬁcits independent of antipsychoticmedication. Surprising-
ly, currently medicated FEP patients showed intact explicit adaptive
salience in behavior, but attenuated adaptive salience-related activation
in the right ACC and insular cortex.HC (n = 19) Statistics Post hoc
10/9 χ2(3) = 5.417
P = 0.144
26.42 (4.1) F(3,78) = 1.155
P = 0.332
18/1 χ2(3) = 0.988
P = 0.988
113 (10) F(3,41) = 1.786
P = 0.165
24.53 (1.2) F(3,77) = 19.920 P b 0.0001 M N H, U N H, A N H, U N A
1.00 (0.0) F(3,77) = 14.184 P b 0.0001 M N H, U N H, A N H, U N A
1.00 (0.0) F(3,77) = 12.439 P b 0.0001 M N H, U N H, U N A
1.00 (0.0) F(3,77) = 13.645 P b 0.0001 M N H, U N H, M N A, U N A
3.00 (0.0) F(3,77) = 21.238 P b 0.0001 M N H, U N H, M N A, U N A, A N H
0.00 (0.0) F(3,75) = 13.036 P b 0.0001 M N H, U N H, A N H
88.63 (4.5) F(3,76) = 24.496 P b 0.0001 M b H, U b H, A b H, U b A
19/0/0 χ2(6) = 105.967
P b 0.0001
0 χ2(3) = 7.323
P = 0.062
1/14/4 χ2(6) = 9.878
P = 0.130
4 (21%) χ2(3) = 4.641
P = 0.200
2.47 (5.8) F(3,78) = 2.799 P = 0.045 U N H
ations: Alcohol n, number of subjects consuming alcohol: No, no alcohol; Mod, moderate
date ofMRI: AF, antipsychotic free; AN, antipsychotic naïve;Med, antipsychoticmedicated;
ng scale; BPRS 9, suspiciousness; BPRS 10, hallucinations; BPRS 11, delusions; FEP-M, FEP
t hoc column; FEP-UM, FEP who were without antipsychotic medication at the time of
= H in the Post hoc column; MWT, intelligence quotient test (multiple choice-vocabulary-
inations, and delusions.
Fig. 1. Brain activation during adaptive salience associatedwith psychosis. Compared to HC, FEP-UM showed lower reward-related responses in the left dorsal cingulate gyrus (P= 0.005
FWE corrected at cluster level). The image is displayed at a threshold of P = 0.005 uncorrected across the whole brain, and the right side of the brain is displayed on the right side of the
ﬁgure.
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cortico–striatal–thalamic circuit (Ongür and Price, 2000), including
the prefrontal cortex, striatum, and thalamus (Roiser et al., 2010). Com-
pared to HC, reduced adaptive salience neural activity in ARMS was
found in the secondary somatosensory cortex and in FEP-UM in the
premotor cortex, and this may contribute to cognitive deﬁcits in early
psychosis (Fusar-Poli et al., 2012). The differences in prefrontal and in-
sular activity between the FEP and HC during adaptive salience process-
ing correspond with a recent theory proposing that abnormalities in
these regions are a key pathophysiological hallmark of psychosisTable 2
Between group differences in regional brain activations identiﬁed by adaptive reward
prediction contrast.
Contrast Cluster level Voxel level Z-score Hemisphere
and region
PFWE-corr. kE PFWE-corr. MNI
ARMS b HC 0.021 710 0.387 56−32 44 4.05 R
supramarginal
G
0.480 36−40 38 3.96 R supramarginal
G
0.742 56−24 34 3.74 R IPL
FEP-UM b HC 0.005 935 0.511 −8−14 42 3.93 L dorsal ACG
0.849 −22−10 56 3.63 L MFG
0.975 −14−24 50 3.40 L precentral G
FEP b HC 0.034 635 0.863 48 6 20 3.61 R precentral G,
IFG
0.958 54 6 10 3.45 R precentral G
0.995 32 16 8 3.27 R insula
FEP-M b HC 0.007 881 0.539 38 24−4 3.91 R insula
0.807 48 6 20 4.04 R precentral G
0.918 36 18 8 3.54 R insula
0.072 527 0.466 18 38 22 3.97 R paracingulate
G
0.581 6 22 32 3.88 R ACG
0.750 0 32 26 3.73 R ACG
FEP-M b ARMS 0.025 684 0.200 8 40 24 4.26 R paracingulate
G
0.319 −2 32 26 4.11 L paracingulate
G, ACG
0.957 4 50 4 3.46 R paracingulate
G
FEP-M b FEP-UM: R insula, kE= 125;MNI 38 26 0; P= 0.072 uncorrected at cluster level.
The data presented here are from ANOVA of 4 included groups (FEP-M, FEP-UM, ARMS,
HC) at a threshold of P = 0.005 uncorrected across the whole brain, where whole FEP
was FEP-M+ FEP-UM. All results with cluster size bigger than 20 voxels are reported.
There were no signiﬁcant differences in the following contrasts: FEP N HC, FEP-UM N HC,
FEP-M N HC, FEP-M vs. FEP-UM, FEP vs. ARMS, FEP-UM vs. ARMS, FEP-M N ARMS, and
ARMS N HC.
Abbreviations: CG, cingulate gyrus; G, gyrus; ACG, anterior cingulate gyrus; FEP-M, with
current antipsychoticmedication FEP; FEP-UM,without current antipsychoticmedication;
FG, frontal gyrus; IFG, inferior frontal gyrus; IPL, inferior parietal lobule; ITG, inferior tem-
poral gyrus; MFG, middle frontal gyrus; MNI, coordinates x y z according to the Montreal
Neurological Institute; MOG, middle occipital gyrus; SFG, superior frontal gyrus; vs., the
contrast was made in both directions (N as well as b).(Palaniyappan and Liddle, 2012). The precentral and insular gyri deﬁcit
seen in the whole FEP group was driven primary by the FEP-M
subgroup.
Behaviorally, FEP-M and FEP-UMdid not respond signiﬁcantly more
quickly to adaptive salience, although they correctly distinguished be-
tween high-probability-reward trials and low-probability-reward trials.
Nevertheless, FEP-M showed additional neural deﬁcits in the insula and
ACC during adaptive salience, which could be related to themodulatory
antipsychotic effect. We did not succeed in conﬁrming aberrant salience
deﬁcits.
Contrary to previous evidence (Roiser et al., 2009, 2010, 2013) and
the reported psychosis-associated neurocognitive impairments (Fusar-
Poli et al., 2012), we found no behavioral differences between FEP,
ARMS and HC during the SAT. Our negative results might be associated
with high within-group variability in motivational salience processing
and dopaminergic dysregulation (Howes and Kapur, 2009), as well as
with possible schizotypy characteristics (Roiser et al., 2010). Additional-
ly, ourHC exhibited higher explicit aberrant salience than the previously
testedHC (Roiser et al., 2009). Furthermore, in contrast to schizophrenia
patients under long-term medication (Roiser et al., 2009), our brieﬂy
medicated FEP patients did not perform signiﬁcantly worse on explicit
adaptive salience.
4.1. Adaptive-salience-processing deﬁcits associated with psychosis
The reduced activity in the somatosensory and premotor cortices in
ARMS and FEP-UM compared to HC is interesting considering recent re-
search on cognition. The SAT, designed to assess the learning of stimu-
lus–reinforcement associations, comprises multiple cognitive tasks,
including tests of sustained attention, maintaining stimulus informa-
tion, and decision making (Roiser et al., 2010). Finally, these cognitive
processes determine participants' motor responses, which are probably
mediated by premotor regions (Hanakawa et al., 2008; Radua et al.,
2014). Both structural (Exner et al., 2006) and functional changes in
the pre-supplementary and supplementary motor areas or premotor
cortex have been reported in schizophrenia and linked to deﬁcits in at-
tention, executive function and time perception (Ojeda et al., 2002;
Ortuño et al., 2002). These neural deﬁcitsmay be a part of a dysfunction-
al cognitive network in early schizophrenia, rather than being speciﬁcal-
ly related to motivational salience dysfunction (Roiser et al., 2013).
Insular neural responses correlated negatively with the severity of
hallucinations in unmedicated FEP patients. These prefrontal neural al-
terations, together with the known striatal and hippocampal alterations
(Roiser et al., 2013), may explain deﬁcits during motivational salience
processing. Ventral striatal neural responses were attenuated in chronic
schizophrenia patients (Juckel et al., 2006b) and deregulated but not
decreased in unmedicated FEP patients (Esslinger et al., 2012). Further-
more, schizophrenia patients exhibited dysregulated but not decreased
activation in the frontal insular and anterior cingulate network
Fig. 2. Brain activation during adaptive salience associatedwith antipsychoticmedication. The FEP-M group compared to the HC, showed attenuated reward-related responses in the right
insula (P=0.007 FWE corrected at cluster level) and the right anterior cingulate (P=0.072 FWE corrected at cluster level). The image is displayed at a threshold of P=0.005uncorrected
across the whole brain, and the right side of the brain is displayed on the right side of the ﬁgure.
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ences, our FEP group did not exhibit a lower striatal neural response
on whole brain analysis.Fig. 3. Relationship between adaptive salience hemodynamic responses and positive psy-
chotic symptoms in unmedicated ﬁrst-episode of psychosis and at-risk mental state indi-
viduals. (a) The adaptive salience hemodynamic response in the right insula (peak voxel
38 24−4, a 15-mm-radius sphere) correlated negatively with hallucination severity in
the unmedicated ﬁrst-episode of psychosis group. (b) The adaptive salience hemodynam-
ic response in the right anterior cingulate gyrus (peak voxel 10 38 22, a 15-mm-radius
sphere) correlated negatively with delusion severity in the unmedicated ﬁrst-episode of
psychosis and at-risk mental state groups.4.2. Adaptive-salience-processing deﬁcits associated with current antipsy-
chotic medication
In contrast to schizophrenia patients on long-term antipsychotic
treatment (Roiser et al., 2009), our brieﬂy medicated FEP patients did
not perform signiﬁcantly worse than HC. However, impaired neural an-
terior cingulate- and insular-responses were associated with antipsy-
chotic medication. The anterior cingulate seems to be especially
sensitive to the antipsychotic effects (Radua et al., 2012; Snitz et al.,
2005). Antipsychotic exposure can affect structure and function even
in the early phases of psychosis (Ho et al., 2011; Nielsen et al., 2012;
Smieskova et al., 2009). Short-term antipsychotic treatment can alter
the neurophysiological cortical response during cognitive functioning
(Fusar-Poli et al., 2007). These results correlate with ‘the ﬁnal common
pathway’ hypothesis of psychosis (Howes and Kapur, 2009): both acute
antipsychotic administration in HC and chronic antipsychotic medica-
tion in schizophrenia patients increase the striatal presynaptic
dopamine synthesis capacity (McGowan et al., 2004). Additionally,
extracellular dopaminergic levels can be elevated in the striatum (Abi-
Dargham et al., 2000) and decreased in the prefrontal cortex in unmed-
icated schizophrenia patients (Abi-Dargham et al., 2012). Antipsy-
chotics may interfere with salience attribution (Schlagenhauf et al.,
2008), although this effect should not be intense, as atypical antipsy-
chotics also inﬂuence other neurotransmitters (Juckel et al., 2006a).
Furthermore, dopamine dysfunction may be particularly prominent
during the very early stages of psychosis (Heinz and Schlagenhauf,
2010). Thus, both of our subgroups, FEP-UM and FEP-M, may have dys-
regulated prefrontal cortical dopamine levels. However, this conclusion
requires testing in longitudinal studies.
Overall, our ﬁndings support a model in which antipsychotics target
brain areas related to pathophysiology in early psychosis, but do not
necessarily suggest that drug treatment causes these alterations
(Fusar-Poli et al., 2013; Radua et al., 2012).4.3. Limitations and future directions
The main limitation of our study is the cross-sectional design. Vari-
ous factors may have inﬂuenced our results, such as different
neurocognitive characterizations (Rausch et al., 2013) and proﬁles of
psychotic symptoms in the FEP subgroups; underlying gray matter def-
icits (Pujol et al., 2013); lack of assessment of the affective state and an-
tidepressants used (Eshel and Roiser, 2010), alcohol (Sullivan et al.,
2013), nicotine or cannabis (Charboneau et al., 2013).We acknowledge
that different interview measures for prodromal symptoms have been
developed that assess either attenuated and/or brief limited psychotic
symptoms, or cognitive basic symptoms. Early prodromal states,mainly
driven by cognitive basic symptoms, may be insufﬁciently represented
when ARMS is deﬁned as in the present study (Rausch et al., 2013). Ad-
ditionally, the differences we studied using SAT may also be related to
stress and motor learning associated with dopamine release (Winton-
Brown et al., 2014). The ARMS groupmay still contain some individuals
22 R. Smieskova et al. / Schizophrenia Research 166 (2015) 17–23with a later transition to psychosis or thosewhowill fully remit (Simon
et al., 2013; Smieskova et al., 2012).
Recent studies have examined task-related integration amongmoti-
vational salience-related regions and have found aberrant functional
and effective connectivity in schizophrenia patients (Diaconescu et al.,
2011; Palaniyappan et al., 2013; White et al., 2010). The differences in
focal brain activity found herewere probably derived fromdysfunction-
al connections to other task-related regions, and this should be ad-
dressed in connectivity studies (Ham et al., 2013; Moran et al., 2013;
Orliac et al., 2013; Schmidt et al., 2013;Wotruba et al., 2014). Addition-
ally, salience network activity also plays an important role in other psy-
chiatric diagnoses (Balthazar et al., 2014; Connolly et al., 2013; Day
et al., 2013; Doll et al., 2013; Pannekoek et al., 2013a,b; Uddin et al.,
2013).4.4. Conclusion
We examined motivational salience processing in ARMS and both
medicated and unmedicated FEP individuals, in comparison to healthy
controls. Our ﬁndings revealed reduced adaptive salience-related hemo-
dynamic responses in the anterior cingulate and insular cortex in rela-
tion to psychosis, collaterally with modulation in these regions by
antipsychotic treatment. To disentangle whether abnormal functional
activity during salience processing is disease- or treatment-related, lon-
gitudinal studies are needed — both before and after transition to psy-
chosis and before and after treatment with antipsychotics.Role of the funding source
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